glp 1 and headaches GLP-1 medications how they may change how we treat in pseudotumor cerebri patients #glp1 #pseudotumorcerebri #hydrocephalus #headaches #migraine Headache and GLP-1 receptor agonists:
Description
This explains why certain individuals respond better to one medication over the other
These data indicated that the status of cell in pancreas and intestine is maintained and the molecular expression level of cell dysfunction is increased after treatment
According to the American Medical Association (AMA), US spending on GLP-1 drugs grew from US$3.1 billion in 2019 to US$27 billion in 2022 an almost nine-fold increase driven largely by off-label use for weight loss
The signal we see is secondary to weight loss
